PIB Summary- 28th September, 2023 | Current Affairs & Hindu Analysis: Daily, Weekly & Monthly - UPSC PDF Download

Dadasaheb Phalke Award 2023

Context
Recently, the Union Minister of Information & Broadcasting announced that legendary actress Ms Waheeda Rehman will be honoured with Dadasaheb Phalke Lifetime Achievement Award for the year 2021.

About Dadasaheb Phalke Award

• Dadasaheb Phalke Award is India’s highest recognition in the cinema industry.
• It is presented annually during the National Film Awards ceremony.
• The Directorate of Film Festivals, under the Ministry of Information and Broadcasting, administers the award.
• Recipients are acknowledged for their remarkable contributions to Indian cinema.
• The award consists of a Swarna Kamal medallion, a shawl, and a cash prize of 10 lakh rupees.
• The award was established to commemorate Dadasaheb Phalke’s significant impact on Indian cinema, earning him the title “the father of Indian cinema.”
• Actress Devika Rani was the inaugural recipient of the award in 1969.

PRIP Scheme

Context
Recently, the union Minister of Chemicals and Fertilizers and Minister of Health & Family Welfare, Government of India launched the Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP).

PRIP Scheme

• The PRIP (Pharmaceutical Research and Innovation in Pharmaceuticals) scheme aims to transition India’s pharmaceutical sector from a cost-based model to one centered on innovation. This transformation will be achieved by bolstering the research infrastructure within the country.

Aim:

• The scheme seeks to foster collaboration between industry and academia to drive research and development (R&D) efforts in priority areas. It also aims to instill a culture of high-quality research and nurture a skilled pool of scientists in India.

Benefits

• The PRIP scheme is expected to establish a sustainable global competitive advantage for India in the pharmaceutical sector. Additionally, it will contribute to the creation of high-quality employment opportunities in the country.

Duration

• The scheme will span five years, covering the period from 2023-24 to 2027-28.

Components

The PRIP scheme comprises two primary components:
Component A: Strengthening Research Infrastructure

• This component focuses on enhancing research infrastructure through the establishment of seven Centers of Excellence (CoEs) at National Institutes of Pharmaceutical Education and Research (NIPERs). These CoEs will be strategically located in predefined areas and have a financial allocation of Rs. 700 Crores.

Component B: Promoting Pharmaceutical Research

• Component B aims to promote research in the pharmaceutical sector by encouraging studies in six priority areas, including New Chemical Entities, Complex Generics (including biosimilars), Medical Devices, Stem Cell Therapy, Orphan Drugs, and Anti-Microbial Resistance. Financial support will be extended to industries, MSMEs, SMEs, startups collaborating with government institutions, and for both in-house and academic research. This component has a total financial allocation of Rs. 4250 Crores.